Mucolytic [EPC]

Mucolytic [EPC] was reported 59064 times

Drugs of the Mucolytic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CONGENITAL HIATUS HERNIA 119 0.5219
1 BODY TINEA 45 0.0804
2 MALIGNANT MELANOMA IN SITU 88 0.0710
3 INHIBITORY DRUG INTERACTION 53 0.0335
4 BREATH SOUNDS ABNORMAL 156 0.0316
5 BENIGN PROSTATIC HYPERPLASIA 154 0.0298
6 MUSCLE CRAMP 52 0.0293
7 BRONCHIECTASIS 179 0.0265
8 NEPHROGENIC ANAEMIA 108 0.0233
9 HAEMORRHAGIC ANAEMIA 102 0.0232
10 EMPYEMA 46 0.0231
11 INFECTION SUSCEPTIBILITY INCREASED 49 0.0224
12 HYPERPARATHYROIDISM SECONDARY 50 0.0199
13 DEVICE RELATED SEPSIS 39 0.0194
14 VENOOCCLUSIVE DISEASE 47 0.0188
15 BLOOD TESTOSTERONE DECREASED 118 0.0172
16 REBOUND ACID HYPERSECRETION 48 0.0159
17 MICTURITION URGENCY 181 0.0158
18 WOUND COMPLICATION 54 0.0157
19 INJECTION SITE PAPULE 68 0.0148
20 LOWER GASTROINTESTINAL HAEMORRHAGE 102 0.0138
21 FULL BLOOD COUNT ABNORMAL 145 0.0137
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 74 0.0136
23 ABDOMINAL ABSCESS 60 0.0136
24 OBSTRUCTIVE AIRWAYS DISORDER 148 0.0133
25 KLEBSIELLA INFECTION 67 0.0132
26 PRE-EXISTING CONDITION IMPROVED 82 0.0131
27 GLUCOSE TOLERANCE IMPAIRED 75 0.0127
28 STAPHYLOCOCCAL BACTERAEMIA 55 0.0126
29 HYPERCHOLESTEROLAEMIA 117 0.0121
30 SPINAL COLUMN STENOSIS 57 0.0121
31 TOXIC EPIDERMAL NECROLYSIS 181 0.0119
32 BODY HEIGHT DECREASED 127 0.0119
33 GOITRE 47 0.0115
34 VITAMIN D DECREASED 98 0.0115
35 ANAPHYLACTOID REACTION 47 0.0114
36 COAGULOPATHY 185 0.0111
37 ENTEROCOCCAL INFECTION 53 0.0110
38 FAECAL INCONTINENCE 52 0.0108
39 DIFFICULTY IN WALKING 37 0.0107
40 STAPHYLOCOCCAL SEPSIS 53 0.0107
41 ENDOMETRIOSIS 51 0.0107
42 TENDON PAIN 80 0.0106
43 THROMBOTIC THROMBOCYTOPENIC PURPURA 36 0.0102
44 ATELECTASIS 96 0.0099
45 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 517 0.0099
46 SINUS HEADACHE 58 0.0098
47 SPINAL OSTEOARTHRITIS 85 0.0097
48 IDIOPATHIC PULMONARY FIBROSIS 38 0.0096
49 MENISCUS INJURY 59 0.0096
50 WALKING AID USER 63 0.0095
51 INITIAL INSOMNIA 98 0.0095
52 DYSPNOEA EXERTIONAL 357 0.0095
53 THERAPY CESSATION 486 0.0095
54 JOINT INJURY 201 0.0094
55 VASCULAR DEVICE INFECTION 42 0.0092
56 CLOSTRIDIUM DIFFICILE COLITIS 98 0.0092
57 PHARYNGOLARYNGEAL PAIN 49 0.0092
58 PRODUCT SUBSTITUTION ISSUE 530 0.0092
59 HYPERLIPIDAEMIA 110 0.0092
60 PROSTATOMEGALY 36 0.0092
61 INCREASED UPPER AIRWAY SECRETION 47 0.0091
62 PRODUCTIVE COUGH 437 0.0091
63 UPPER-AIRWAY COUGH SYNDROME 75 0.0091
64 SKIN ABRASION 43 0.0091
65 INTENTIONAL DEVICE MISUSE 40 0.0091
66 ACUTE RESPIRATORY FAILURE 174 0.0090
67 AMMONIA INCREASED 46 0.0090
68 RALES 52 0.0089
69 PULMONARY FUNCTION TEST DECREASED 39 0.0089
70 BLOOD CALCIUM INCREASED 78 0.0089
71 MUSCLE FATIGUE 37 0.0087
72 LACERATION 82 0.0087
73 STOMACH DISCOMFORT 44 0.0085
74 BUNDLE BRANCH BLOCK RIGHT 39 0.0085
75 TONGUE DISCOLOURATION 37 0.0085
76 SINUS CONGESTION 114 0.0084
77 CLOSTRIDIUM DIFFICILE INFECTION 183 0.0084
78 LOCAL SWELLING 146 0.0084
79 INCREASED TENDENCY TO BRUISE 77 0.0084
80 POOR QUALITY SLEEP 180 0.0084
81 MIDDLE INSOMNIA 156 0.0083
82 BLOOD MAGNESIUM DECREASED 72 0.0083
83 PERONEAL NERVE PALSY 47 0.0083
84 TRANSIENT ISCHAEMIC ATTACK 279 0.0083
85 HEPATIC ENCEPHALOPATHY 77 0.0082
86 END STAGE RENAL DISEASE 149 0.0082
87 PELVIC PAIN 148 0.0081
88 FULL BLOOD COUNT DECREASED 164 0.0081
89 EXOSTOSIS 74 0.0081
90 DYSMENORRHOEA 107 0.0081
91 SMALL INTESTINAL OBSTRUCTION 99 0.0080
92 VITAMIN D DEFICIENCY 78 0.0080
93 BRAIN OEDEMA 101 0.0080
94 DECREASED INTEREST 47 0.0080
95 TENDERNESS 83 0.0080
96 HAEMATOCRIT DECREASED 157 0.0079
97 STEVENS-JOHNSON SYNDROME 176 0.0079
98 ABDOMINAL HERNIA 36 0.0079
99 LEUKOCYTOSIS 141 0.0078
100 BLOOD POTASSIUM DECREASED 234 0.0078
101 MENORRHAGIA 152 0.0077
102 SKIN TIGHTNESS 36 0.0076
103 INJECTION SITE NODULE 84 0.0076
104 BALANCE DISORDER 658 0.0076
105 ACUTE HEPATIC FAILURE 104 0.0076
106 BLOOD IRON DECREASED 89 0.0075
107 BACTERAEMIA 89 0.0075
108 FLUID OVERLOAD 109 0.0075
109 ROTATOR CUFF SYNDROME 96 0.0075
110 SOMNAMBULISM 49 0.0075
111 HUMERUS FRACTURE 36 0.0075
112 ENERGY INCREASED 44 0.0074
113 TRICUSPID VALVE INCOMPETENCE 59 0.0074
114 MUSCLE ATROPHY 94 0.0074
115 MULTIPLE ALLERGIES 58 0.0074
116 UTERINE LEIOMYOMA 54 0.0074
117 ACTIVITIES OF DAILY LIVING IMPAIRED 145 0.0073
118 THERAPY CHANGE 72 0.0073
119 CHOLECYSTITIS CHRONIC 49 0.0073
120 TENDONITIS 113 0.0073
121 MUSCLE STRAIN 63 0.0073
122 COMPRESSION FRACTURE 39 0.0073
123 HYPOXIA 255 0.0072
124 GASTROOESOPHAGEAL REFLUX DISEASE 576 0.0071
125 ANORECTAL DISCOMFORT 38 0.0071
126 IMPAIRED DRIVING ABILITY 81 0.0071
127 PRODUCT FORMULATION ISSUE 47 0.0071
128 PURPURA 63 0.0071
129 PHOTOPSIA 45 0.0071
130 FLATULENCE 403 0.0071
131 HOSPICE CARE 70 0.0071
132 NOCTURIA 86 0.0071
133 UPPER GASTROINTESTINAL HAEMORRHAGE 119 0.0071
134 HYPERKERATOSIS 39 0.0071
135 IMPAIRED WORK ABILITY 151 0.0071
136 MUSCULOSKELETAL PAIN 370 0.0071
137 BRUXISM 38 0.0070
138 BREAST TENDERNESS 53 0.0070
139 CORONARY ARTERY DISEASE 213 0.0070
140 INTERVERTEBRAL DISC DEGENERATION 65 0.0070
141 HYPOVOLAEMIA 41 0.0070
142 PERIPHERAL VASCULAR DISORDER 36 0.0070
143 TEMPERATURE INTOLERANCE 72 0.0070
144 SLEEP APNOEA SYNDROME 133 0.0070
145 TENDON RUPTURE 86 0.0070
146 RASH PAPULAR 156 0.0070
147 EXERCISE TOLERANCE DECREASED 40 0.0069
148 SINUSITIS 711 0.0069
149 SCAB 79 0.0069
150 VAGINAL DISCHARGE 70 0.0069
151 MUSCLE SPASTICITY 85 0.0069
152 SCREAMING 44 0.0069
153 CELLULITIS 348 0.0069
154 MENSTRUAL DISORDER 57 0.0069
155 SKIN WARM 40 0.0069
156 VENTRICULAR EXTRASYSTOLES 71 0.0068
157 FLANK PAIN 64 0.0068
158 INTERNATIONAL NORMALISED RATIO INCREASED 194 0.0068
159 SQUAMOUS CELL CARCINOMA OF SKIN 41 0.0068
160 RESTLESS LEGS SYNDROME 123 0.0068
161 PROCTALGIA 43 0.0067
162 OSTEOPENIA 101 0.0066
163 CARDIAC FLUTTER 43 0.0066
164 PANIC REACTION 48 0.0066
165 POOR QUALITY DRUG ADMINISTERED 43 0.0066
166 ATRIAL FLUTTER 53 0.0066
167 HAND FRACTURE 47 0.0066
168 URINE ODOUR ABNORMAL 39 0.0066
169 DRY MOUTH 538 0.0066
170 BLOOD UREA INCREASED 111 0.0066
171 PAROSMIA 50 0.0066
172 FEELING JITTERY 126 0.0066
173 GROIN PAIN 58 0.0066
174 CHROMATURIA 149 0.0066
175 HYPOAESTHESIA ORAL 99 0.0066
176 NERVE INJURY 73 0.0066
177 DEFAECATION URGENCY 46 0.0066
178 AGEUSIA 163 0.0065
179 BLOOD COUNT ABNORMAL 99 0.0065
180 SINUS DISORDER 129 0.0065
181 MUSCLE TIGHTNESS 105 0.0065
182 PRURITUS GENERALISED 140 0.0065
183 LUNG INFILTRATION 57 0.0064
184 HYPERAESTHESIA 53 0.0064
185 METRORRHAGIA 110 0.0064
186 VISUAL DISTURBANCE 37 0.0064
187 BRONCHITIS 476 0.0064
188 BLOOD ALBUMIN DECREASED 51 0.0064
189 VAGINAL HAEMORRHAGE 279 0.0064
190 HIATUS HERNIA 83 0.0064
191 INJECTION SITE HAEMORRHAGE 509 0.0064
192 SEASONAL ALLERGY 90 0.0064
193 PROTHROMBIN TIME PROLONGED 38 0.0063
194 ARTHROPOD BITE 47 0.0063
195 PULMONARY HYPERTENSION 132 0.0063
196 HYPERCALCAEMIA 78 0.0063
197 PANIC ATTACK 230 0.0063
198 PULMONARY CONGESTION 83 0.0063
199 URINE OUTPUT DECREASED 55 0.0063
200 JOINT STIFFNESS 165 0.0063
201 SPINAL COMPRESSION FRACTURE 52 0.0063
202 WHEEZING 372 0.0063
203 CORONARY ARTERY OCCLUSION 86 0.0063
204 LIGAMENT SPRAIN 62 0.0063
205 POST-TRAUMATIC STRESS DISORDER 42 0.0063
206 CHRONIC KIDNEY DISEASE 475 0.0062
207 RESPIRATORY TRACT CONGESTION 99 0.0062
208 GALLBLADDER DISORDER 111 0.0062
209 HICCUPS 51 0.0062
210 MOOD SWINGS 198 0.0062
211 UPPER RESPIRATORY TRACT INFECTION 287 0.0062
212 BREAST PAIN 66 0.0062
213 WRIST FRACTURE 74 0.0062
214 FLUSHING 627 0.0062
215 SUPRAVENTRICULAR TACHYCARDIA 59 0.0062
216 GASTROINTESTINAL HAEMORRHAGE 515 0.0062
217 TINNITUS 283 0.0062
218 INJECTION SITE BRUISING 490 0.0061
219 RIGHT VENTRICULAR FAILURE 43 0.0061
220 TENDON DISORDER 40 0.0061
221 HOT FLUSH 462 0.0061
222 RENAL FAILURE ACUTE 260 0.0061
223 PERIPHERAL COLDNESS 84 0.0061
224 MUSCULAR WEAKNESS 695 0.0061
225 FREQUENT BOWEL MOVEMENTS 165 0.0061
226 HYPERSOMNIA 175 0.0061
227 CANDIDA INFECTION 103 0.0061
228 DEEP VEIN THROMBOSIS 395 0.0061
229 RHINITIS 49 0.0061
230 HYPOPHAGIA 155 0.0061
231 CONTUSION 583 0.0060
232 NIGHT SWEATS 195 0.0060
233 HYPOALBUMINAEMIA 47 0.0060
234 THERAPEUTIC RESPONSE UNEXPECTED 271 0.0060
235 BLOOD ALKALINE PHOSPHATASE INCREASED 150 0.0060
236 APHONIA 84 0.0060
237 BLOOD URINE PRESENT 114 0.0060
238 DRY THROAT 61 0.0060
239 MENSTRUATION DELAYED 65 0.0060
240 POLLAKIURIA 250 0.0060
241 TOOTH INFECTION 79 0.0060
242 INSOMNIA 1594 0.0060
243 RENAL FAILURE CHRONIC 46 0.0060
244 GASTROENTERITIS VIRAL 108 0.0060
245 OSTEOPOROSIS 246 0.0060
246 PLEURAL EFFUSION 363 0.0060
247 ONYCHOCLASIS 41 0.0060
248 ENTERITIS 38 0.0059
249 TOOTH DISORDER 132 0.0059
250 OEDEMA PERIPHERAL 723 0.0059
251 RIB FRACTURE 122 0.0059
252 TROPONIN INCREASED 45 0.0059
253 GAIT DISTURBANCE 1131 0.0059
254 SCAR 101 0.0059
255 DISTURBANCE IN ATTENTION 318 0.0059
256 ASPARTATE AMINOTRANSFERASE INCREASED 313 0.0059
257 ARTERIOSCLEROSIS CORONARY ARTERY 39 0.0059
258 DIVERTICULITIS 163 0.0059
259 CYST 73 0.0059
260 INFUSION SITE SWELLING 37 0.0059
261 URINARY INCONTINENCE 174 0.0059
262 ATRIAL FIBRILLATION 571 0.0059
263 ABNORMAL FAECES 48 0.0059
264 NASAL CONGESTION 344 0.0058
265 NERVE COMPRESSION 54 0.0058
266 RHINORRHOEA 378 0.0058
267 HERPES SIMPLEX 38 0.0058
268 BLADDER DISORDER 58 0.0058
269 BLOOD SODIUM DECREASED 110 0.0058
270 MUSCLE SPASMS 1068 0.0058
271 ANOREXIA 75 0.0058
272 SENSATION OF FOREIGN BODY 49 0.0058
273 RASH PRURITIC 315 0.0058
274 RENAL TUBULAR NECROSIS 57 0.0058
275 RASH GENERALISED 150 0.0058
276 RENAL CYST 46 0.0058
277 LYMPHOEDEMA 40 0.0058
278 DIZZINESS POSTURAL 56 0.0058
279 DYSGEUSIA 429 0.0058
280 RECTAL HAEMORRHAGE 248 0.0058
281 DECUBITUS ULCER 47 0.0058
282 HYPOKALAEMIA 266 0.0058
283 BONE DISORDER 105 0.0058
284 PULMONARY HAEMORRHAGE 45 0.0057
285 NASAL DRYNESS 36 0.0057
286 FALL 1909 0.0057
287 LUNG INFECTION 89 0.0057
288 CYANOSIS 90 0.0057
289 ABNORMAL LOSS OF WEIGHT 39 0.0057
290 ABASIA 141 0.0057
291 TOOTHACHE 103 0.0057
292 RESPIRATORY TRACT INFECTION 148 0.0057
293 NASAL DISCOMFORT 45 0.0057
294 ABDOMINAL DISTENSION 592 0.0057
295 AORTIC ANEURYSM 43 0.0056
296 BLOOD THYROID STIMULATING HORMONE INCREASED 52 0.0056
297 EAR DISCOMFORT 58 0.0056
298 EMPHYSEMA 57 0.0056
299 PAIN IN JAW 160 0.0056
300 PARAESTHESIA 887 0.0056
301 IRON DEFICIENCY ANAEMIA 52 0.0056
302 MALNUTRITION 63 0.0056
303 DIVERTICULUM 40 0.0056
304 BACTERIAL INFECTION 105 0.0056
305 ACIDOSIS 43 0.0056
306 MUSCULOSKELETAL CHEST PAIN 87 0.0056
307 VIRAL INFECTION 187 0.0056
308 PNEUMONIA 1816 0.0056
309 STAPHYLOCOCCAL INFECTION 185 0.0056
310 NAIL DISORDER 49 0.0056
311 TOOTH ABSCESS 57 0.0056
312 LABORATORY TEST ABNORMAL 165 0.0056
313 SECRETION DISCHARGE 70 0.0056
314 SLUGGISHNESS 57 0.0056
315 ORAL HERPES 109 0.0056
316 ERUCTATION 108 0.0056
317 MENTAL STATUS CHANGES 155 0.0056
318 CONSTIPATION 1217 0.0056
319 HEART RATE IRREGULAR 126 0.0056
320 CARPAL TUNNEL SYNDROME 78 0.0056
321 UNEVALUABLE EVENT 421 0.0056
322 DYSPHONIA 325 0.0056
323 RESPIRATORY FAILURE 405 0.0055
324 ASTHENIA 2088 0.0055
325 MUSCLE TWITCHING 128 0.0055
326 SKIN DISORDER 185 0.0055
327 FEELING HOT 340 0.0055
328 BRONCHOSPASM 79 0.0055
329 TOOTH FRACTURE 61 0.0055
330 HYPOMAGNESAEMIA 77 0.0055
331 NECK PAIN 309 0.0055
332 DEVICE RELATED INFECTION 85 0.0055
333 HAEMOPTYSIS 154 0.0055
334 FEELING DRUNK 41 0.0055
335 BACK INJURY 60 0.0055
336 RESPIRATION ABNORMAL 38 0.0055
337 HYPOAESTHESIA 825 0.0055
338 BREAST MASS 37 0.0055
339 RED BLOOD CELL COUNT DECREASED 157 0.0055
340 BOWEL MOVEMENT IRREGULARITY 42 0.0055
341 SPUTUM DISCOLOURED 52 0.0055
342 ELECTROCARDIOGRAM ABNORMAL 43 0.0055
343 MITRAL VALVE INCOMPETENCE 62 0.0055
344 CRYING 199 0.0055
345 BACK PAIN 1267 0.0054
346 CHILLS 639 0.0054
347 DYSSTASIA 159 0.0054
348 INTERVERTEBRAL DISC PROTRUSION 119 0.0054
349 TACHYPNOEA 74 0.0054
350 TRANSFUSION 57 0.0054
351 BURSITIS 66 0.0054
352 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 387 0.0054
353 SKIN INFECTION 61 0.0054
354 FURUNCLE 43 0.0054
355 IMPAIRED QUALITY OF LIFE 78 0.0054
356 LOW DENSITY LIPOPROTEIN INCREASED 42 0.0054
357 PHOTOPHOBIA 102 0.0054
358 HEAD DISCOMFORT 96 0.0054
359 PAIN OF SKIN 146 0.0054
360 DYSPEPSIA 533 0.0054
361 CATARACT 322 0.0054
362 PARAESTHESIA ORAL 78 0.0054
363 EAR PAIN 105 0.0054
364 INCONTINENCE 57 0.0054
365 NEURALGIA 131 0.0054
366 DEPRESSION 1224 0.0054
367 INJECTION SITE PRURITUS 360 0.0054
368 HEAD INJURY 170 0.0054
369 MENTAL IMPAIRMENT 130 0.0054
370 DEHYDRATION 715 0.0054
371 BLOOD CALCIUM DECREASED 60 0.0053
372 PULMONARY EMBOLISM 507 0.0053
373 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 256 0.0053
374 DRUG EFFECT DECREASED 287 0.0053
375 OROPHARYNGEAL PAIN 493 0.0053
376 LETHARGY 306 0.0053
377 FATIGUE 4141 0.0053
378 HAEMOGLOBIN DECREASED 546 0.0053
379 FEELING ABNORMAL 1274 0.0053
380 ORAL CANDIDIASIS 70 0.0053
381 PRODUCT DOSE OMISSION 347 0.0053
382 UROSEPSIS 49 0.0053
383 DYSURIA 195 0.0053
384 ASPIRATION 58 0.0053
385 URINARY TRACT INFECTION 903 0.0053
386 RASH MACULAR 185 0.0053
387 HEPATOMEGALY 52 0.0053
388 ORTHOSTATIC HYPOTENSION 92 0.0053
389 GINGIVAL PAIN 42 0.0053
390 PALPITATIONS 618 0.0053
391 COLD SWEAT 93 0.0053
392 MYALGIA 897 0.0053
393 ACNE 400 0.0053
394 PELVIC FRACTURE 41 0.0053
395 NERVOUSNESS 275 0.0053
396 METABOLIC ACIDOSIS 168 0.0052
397 ECCHYMOSIS 36 0.0052
398 CHEST DISCOMFORT 537 0.0052
399 HAEMODIALYSIS 44 0.0052
400 NEUROPATHY PERIPHERAL 497 0.0052
401 EAR INFECTION 139 0.0052
402 JOINT EFFUSION 36 0.0052
403 BLOOD BILIRUBIN INCREASED 141 0.0052
404 RASH PUSTULAR 38 0.0052
405 ABNORMAL DREAMS 144 0.0052
406 GASTRIC ULCER 99 0.0052
407 FEELING COLD 145 0.0052
408 WEIGHT DECREASED 1452 0.0052
409 INFLUENZA LIKE ILLNESS 428 0.0052
410 DISORIENTATION 206 0.0052
411 LARGE INTESTINE POLYP 36 0.0052
412 HIP FRACTURE 167 0.0052
413 VITREOUS FLOATERS 51 0.0052
414 PRESYNCOPE 126 0.0052
415 WRONG TECHNIQUE IN DRUG USAGE PROCESS 188 0.0052
416 SNEEZING 116 0.0052
417 INJECTION SITE INDURATION 67 0.0052
418 FAECES DISCOLOURED 112 0.0052
419 DRUG DOSE OMISSION 853 0.0052
420 ANAEMIA 983 0.0051
421 DENTAL CARIES 57 0.0051
422 INJECTION SITE ERYTHEMA 639 0.0051
423 ABDOMINAL PAIN 1193 0.0051
424 OSTEOARTHRITIS 217 0.0051
425 MUSCULOSKELETAL DISCOMFORT 88 0.0051
426 DERMATITIS BULLOUS 37 0.0051
427 HEART RATE INCREASED 506 0.0051
428 DIZZINESS 2545 0.0051
429 BLOOD TRIGLYCERIDES INCREASED 90 0.0051
430 FEAR 137 0.0051
431 PNEUMONIA ASPIRATION 127 0.0051
432 THROAT IRRITATION 228 0.0051
433 HYDRONEPHROSIS 38 0.0051
434 THERMAL BURN 36 0.0051
435 SEPSIS 565 0.0051
436 BASAL CELL CARCINOMA 79 0.0051
437 FOOT FRACTURE 96 0.0051
438 STOMATITIS 307 0.0051
439 COUGH 1419 0.0051
440 INJECTION SITE WARMTH 104 0.0051
441 DECREASED APPETITE 1173 0.0050
442 TREMOR 838 0.0050
443 CARDIOMEGALY 62 0.0050
444 ORAL DISCOMFORT 70 0.0050
445 DIARRHOEA HAEMORRHAGIC 47 0.0050
446 PHOTOSENSITIVITY REACTION 83 0.0050
447 OBESITY 80 0.0050
448 GASTROINTESTINAL INFECTION 45 0.0050
449 ALANINE AMINOTRANSFERASE INCREASED 308 0.0050
450 DYSPNOEA 2839 0.0050
451 PSEUDOMONAS INFECTION 43 0.0050
452 POLYURIA 41 0.0050
453 MOTOR DYSFUNCTION 51 0.0050
454 CHOLELITHIASIS 164 0.0050
455 POST PROCEDURAL COMPLICATION 96 0.0050
456 IMPAIRED HEALING 164 0.0050
457 CYSTITIS 159 0.0050
458 SQUAMOUS CELL CARCINOMA 47 0.0050
459 PARANOIA 86 0.0050
460 HEPATOTOXICITY 111 0.0050
461 SENSORY DISTURBANCE 80 0.0050
462 FISTULA 56 0.0050
463 FLUID RETENTION 253 0.0050
464 RETCHING 106 0.0050
465 BURNING SENSATION 348 0.0050
466 PYELONEPHRITIS 43 0.0050
467 HYPERHIDROSIS 639 0.0050
468 SCIATICA 79 0.0050
469 BLOOD CREATININE INCREASED 323 0.0049
470 DIARRHOEA 3190 0.0049
471 SEPTIC SHOCK 215 0.0049
472 PHARYNGEAL OEDEMA 76 0.0049
473 HAIR TEXTURE ABNORMAL 66 0.0049
474 EPISTAXIS 369 0.0049
475 BACK DISORDER 80 0.0049
476 MUSCULOSKELETAL STIFFNESS 431 0.0049
477 BLOOD CHOLESTEROL INCREASED 229 0.0049
478 CONCUSSION 38 0.0049
479 PNEUMONIA BACTERIAL 45 0.0049
480 DELUSION 76 0.0049
481 PERICARDIAL EFFUSION 113 0.0049
482 ARTHRITIS 384 0.0049
483 ANXIETY 1389 0.0049
484 COORDINATION ABNORMAL 68 0.0049
485 IMMUNOSUPPRESSION 43 0.0049
486 HERPES ZOSTER 280 0.0049
487 HYPOPHOSPHATAEMIA 36 0.0049
488 INJECTION SITE PAIN 1494 0.0049
489 BEDRIDDEN 64 0.0049
490 BLOOD POTASSIUM INCREASED 79 0.0049
491 MACULAR DEGENERATION 58 0.0049
492 GOUT 87 0.0048
493 PNEUMONITIS 132 0.0048
494 MEMORY IMPAIRMENT 665 0.0048
495 WHITE BLOOD CELL COUNT DECREASED 523 0.0048
496 ORAL PAIN 108 0.0048
497 CHEST PAIN 893 0.0048
498 ANGER 163 0.0048
499 MUSCLE DISORDER 39 0.0048
500 BONE PAIN 282 0.0048
501 FOOD ALLERGY 37 0.0048
502 SKIN HAEMORRHAGE 71 0.0048
503 CHOLECYSTITIS 57 0.0048
504 HALLUCINATION, VISUAL 101 0.0048
505 RENAL FAILURE 635 0.0048
506 LIVER FUNCTION TEST ABNORMAL 139 0.0048
507 HAEMORRHOIDS 93 0.0048
508 ANOSMIA 69 0.0048
509 HYPOKINESIA 69 0.0047
510 PAIN IN EXTREMITY 1400 0.0047
511 NODULE 62 0.0047
512 MOBILITY DECREASED 340 0.0047
513 APATHY 69 0.0047
514 SWELLING FACE 308 0.0047
515 MOOD ALTERED 129 0.0047
516 RASH ERYTHEMATOUS 226 0.0047
517 GASTROINTESTINAL PAIN 52 0.0047
518 HEPATIC STEATOSIS 88 0.0047
519 NEPHROPATHY TOXIC 53 0.0047
520 SINUS TACHYCARDIA 67 0.0047
521 UPPER LIMB FRACTURE 94 0.0047
522 SKIN EXFOLIATION 398 0.0047
523 ANKLE FRACTURE 73 0.0047
524 FUNGAL INFECTION 157 0.0047
525 ABDOMINAL PAIN LOWER 119 0.0047
526 PULMONARY ARTERIAL HYPERTENSION 68 0.0047
527 PERIPHERAL SWELLING 722 0.0047
528 OXYGEN SATURATION DECREASED 263 0.0047
529 ACUTE KIDNEY INJURY 716 0.0047
530 SHOCK HAEMORRHAGIC 38 0.0047
531 PYREXIA 1615 0.0047
532 MIGRAINE 445 0.0047
533 LYMPHADENOPATHY 165 0.0047
534 BODY TEMPERATURE INCREASED 95 0.0047
535 NAUSEA 3685 0.0047
536 DRUG EFFECT INCOMPLETE 169 0.0046
537 BLISTER 261 0.0046
538 THIRST 83 0.0046
539 ENCEPHALOPATHY 114 0.0046
540 PULMONARY MASS 69 0.0046
541 DRY SKIN 618 0.0046
542 MULTI-ORGAN FAILURE 80 0.0046
543 TACHYCARDIA 411 0.0046
544 APNOEA 36 0.0046
545 RENAL PAIN 49 0.0046
546 PULMONARY OEDEMA 207 0.0046
547 SKIN BURNING SENSATION 331 0.0046
548 PHARYNGITIS STREPTOCOCCAL 50 0.0046
549 CONFUSIONAL STATE 746 0.0046
550 EYE INFECTION 52 0.0046
551 HAEMATOMA 119 0.0046
552 LIMB DISCOMFORT 142 0.0046
553 HEADACHE 2875 0.0046
554 SKIN DISCOLOURATION 210 0.0046
555 INJECTION SITE URTICARIA 112 0.0046
556 ABDOMINAL PAIN UPPER 939 0.0046
557 INJECTION SITE EXTRAVASATION 56 0.0045
558 PLASMA CELL MYELOMA 177 0.0045
559 ARTHRALGIA 1882 0.0045
560 OEDEMA 245 0.0045
561 EYE SWELLING 168 0.0045
562 PLATELET COUNT DECREASED 481 0.0045
563 SKIN LACERATION 49 0.0045
564 LIP SWELLING 150 0.0045
565 HAEMATOCHEZIA 248 0.0045
566 OBSESSIVE-COMPULSIVE DISORDER 36 0.0045
567 NASOPHARYNGITIS 826 0.0045
568 NIGHTMARE 155 0.0045
569 SKIN IRRITATION 205 0.0045
570 SENSORY LOSS 36 0.0045
571 ARTERIOSCLEROSIS 42 0.0045
572 THINKING ABNORMAL 83 0.0044
573 LOSS OF LIBIDO 40 0.0044
574 DERMATITIS 93 0.0044
575 GLOSSODYNIA 99 0.0044
576 VISION BLURRED 606 0.0044
577 INCORRECT DRUG ADMINISTRATION DURATION 124 0.0044
578 BLOOD PRESSURE INCREASED 674 0.0044
579 APPLICATION SITE PAIN 97 0.0044
580 FIBROMYALGIA 107 0.0044
581 CARDIOMYOPATHY 65 0.0044
582 ERYTHEMA 904 0.0044
583 INJECTION SITE MASS 162 0.0044
584 CHOLECYSTECTOMY 50 0.0044
585 ESCHERICHIA INFECTION 36 0.0044
586 GENERALISED OEDEMA 54 0.0044
587 CARDIAC FAILURE CONGESTIVE 350 0.0044
588 PHARYNGITIS 54 0.0043
589 HYPERTENSION 922 0.0043
590 BLOOD TEST ABNORMAL 61 0.0043
591 APHASIA 131 0.0043
592 SLEEP DISORDER 306 0.0043
593 SUBDURAL HAEMATOMA 62 0.0043
594 PULMONARY FIBROSIS 83 0.0043
595 THROAT TIGHTNESS 117 0.0043
596 SPEECH DISORDER 226 0.0043
597 WEIGHT INCREASED 963 0.0043
598 JOINT SWELLING 519 0.0043
599 VERTIGO 262 0.0043
600 ATAXIA 51 0.0043
601 ACUTE RESPIRATORY DISTRESS SYNDROME 76 0.0043
602 ERYTHEMA MULTIFORME 40 0.0043
603 PNEUMOTHORAX 68 0.0043
604 URINARY RETENTION 143 0.0043
605 ASTHMA 484 0.0043
606 THYROID DISORDER 66 0.0043
607 CARDIAC MURMUR 37 0.0043
608 RESPIRATORY DISTRESS 118 0.0043
609 DRUG ADMINISTERED AT INAPPROPRIATE SITE 45 0.0043
610 UNRESPONSIVE TO STIMULI 110 0.0043
611 MENSTRUATION IRREGULAR 114 0.0043
612 NEPHROLITHIASIS 195 0.0042
613 COLITIS 161 0.0042
614 AMNESIA 276 0.0042
615 SPINAL FRACTURE 85 0.0042
616 DEPRESSED MOOD 224 0.0042
617 HUNGER 59 0.0042
618 KIDNEY INFECTION 83 0.0042
619 HYPONATRAEMIA 238 0.0042
620 PANCYTOPENIA 235 0.0042
621 OSTEOMYELITIS 76 0.0042
622 MANIA 69 0.0042
623 HAEMATURIA 143 0.0042
624 QUALITY OF LIFE DECREASED 56 0.0042
625 SCRATCH 44 0.0042
626 LACRIMATION INCREASED 126 0.0042
627 MULTIPLE SCLEROSIS RELAPSE 285 0.0042
628 CONJUNCTIVITIS 77 0.0041
629 SOMNOLENCE 833 0.0041
630 RETINAL DETACHMENT 38 0.0041
631 MYDRIASIS 53 0.0041
632 EYE HAEMORRHAGE 55 0.0041
633 ABDOMINAL DISCOMFORT 691 0.0041
634 HYPOTENSION 826 0.0041
635 ANAL INCONTINENCE 37 0.0041
636 PRODUCT ODOUR ABNORMAL 43 0.0041
637 OVARIAN CYST 41 0.0041
638 ALOPECIA 805 0.0041
639 WHITE BLOOD CELL COUNT INCREASED 157 0.0041
640 COGNITIVE DISORDER 191 0.0041
641 RECALLED PRODUCT ADMINISTERED 39 0.0041
642 EATING DISORDER 87 0.0041
643 HYPOTHYROIDISM 130 0.0041
644 SWOLLEN TONGUE 127 0.0041
645 FOOT DEFORMITY 45 0.0041
646 RESPIRATORY RATE INCREASED 36 0.0041
647 NEUTROPHIL COUNT DECREASED 165 0.0040
648 DRY EYE 202 0.0040
649 APPLICATION SITE ERYTHEMA 106 0.0040
650 INJECTION SITE RASH 124 0.0040
651 MULTIPLE SCLEROSIS 193 0.0040
652 OESOPHAGITIS 44 0.0040
653 RESTLESSNESS 147 0.0040
654 JAUNDICE 108 0.0040
655 SPLENOMEGALY 47 0.0040
656 SKIN LESION 110 0.0040
657 IRRITABILITY 241 0.0040
658 HALLUCINATION 302 0.0040
659 EYE PAIN 226 0.0040
660 INJECTION SITE DISCOLOURATION 50 0.0040
661 DYSARTHRIA 150 0.0040
662 RESPIRATORY DISORDER 119 0.0040
663 LOCALISED INFECTION 96 0.0040
664 INFLUENZA 442 0.0040
665 BIPOLAR DISORDER 43 0.0040
666 POST PROCEDURAL HAEMORRHAGE 46 0.0039
667 HYPOTHERMIA 40 0.0039
668 SKIN ULCER 102 0.0039
669 ACUTE MYOCARDIAL INFARCTION 116 0.0039
670 ERECTILE DYSFUNCTION 101 0.0039
671 RASH 1713 0.0039
672 PETECHIAE 41 0.0039
673 SUICIDAL IDEATION 359 0.0039
674 BLOOD PRESSURE FLUCTUATION 94 0.0039
675 FACE OEDEMA 66 0.0039
676 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
677 INJURY 275 0.0039
678 AGITATION 287 0.0039
679 HYPERKALAEMIA 137 0.0039
680 DYSPHAGIA 370 0.0039
681 LUNG DISORDER 191 0.0039
682 DECREASED ACTIVITY 42 0.0039
683 DIPLOPIA 101 0.0039
684 JOINT DISLOCATION 41 0.0039
685 ASCITES 114 0.0039
686 MADAROSIS 45 0.0039
687 VENTRICULAR TACHYCARDIA 64 0.0039
688 VENTRICULAR FIBRILLATION 43 0.0039
689 TRANSAMINASES INCREASED 86 0.0039
690 MOVEMENT DISORDER 124 0.0039
691 GASTRIC DISORDER 132 0.0038
692 HEPATIC ENZYME INCREASED 262 0.0038
693 VOMITING 1805 0.0038
694 INTESTINAL PERFORATION 43 0.0038
695 THROMBOSIS 308 0.0038
696 VISUAL ACUITY REDUCED 127 0.0038
697 PRURITUS 1468 0.0038
698 MELAENA 84 0.0038
699 FEBRILE NEUTROPENIA 252 0.0038
700 SALIVARY HYPERSECRETION 38 0.0038
701 INJECTION SITE SWELLING 291 0.0038
702 MEDICATION ERROR 211 0.0038
703 PSYCHOMOTOR HYPERACTIVITY 63 0.0038
704 TASTE DISORDER 77 0.0038
705 MASS 53 0.0038
706 ELECTROLYTE IMBALANCE 44 0.0038
707 EYELID OEDEMA 44 0.0038
708 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 207 0.0038
709 COELIAC DISEASE 37 0.0038
710 ANGINA PECTORIS 108 0.0038
711 INTERNAL HAEMORRHAGE 43 0.0038
712 GASTRITIS 99 0.0038
713 HEPATIC FAILURE 113 0.0037
714 GLAUCOMA 72 0.0037
715 RENAL INJURY 111 0.0037
716 GINGIVAL BLEEDING 51 0.0037
717 BLOOD PRESSURE DECREASED 248 0.0037
718 RASH MACULO-PAPULAR 83 0.0037
719 JOINT RANGE OF MOTION DECREASED 50 0.0037
720 URTICARIA 624 0.0037
721 BLOOD PRESSURE ABNORMAL 74 0.0037
722 WOUND 104 0.0037
723 IMMUNE SYSTEM DISORDER 49 0.0037
724 SYNCOPE 372 0.0037
725 PSORIASIS 485 0.0037
726 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
727 NEUROLEPTIC MALIGNANT SYNDROME 44 0.0037
728 PROSTATIC SPECIFIC ANTIGEN INCREASED 51 0.0037
729 PHARMACEUTICAL PRODUCT COMPLAINT 96 0.0037
730 LOWER LIMB FRACTURE 71 0.0037
731 CHOKING 72 0.0037
732 DELIRIUM 128 0.0037
733 DERMATITIS CONTACT 42 0.0037
734 LYMPHOCYTE COUNT DECREASED 65 0.0037
735 EJECTION FRACTION DECREASED 57 0.0037
736 THROMBOCYTOPENIA 410 0.0037
737 DIALYSIS 52 0.0037
738 INFUSION SITE PAIN 47 0.0036
739 LIMB INJURY 99 0.0036
740 CONDITION AGGRAVATED 1108 0.0036
741 IRRITABLE BOWEL SYNDROME 78 0.0036
742 SKIN FISSURES 71 0.0036
743 GASTROENTERITIS 53 0.0036
744 TUBULOINTERSTITIAL NEPHRITIS 68 0.0036
745 HYPERSENSITIVITY 671 0.0036
746 NEUTROPHIL COUNT INCREASED 37 0.0036
747 DEAFNESS 94 0.0036
748 LOSS OF CONSCIOUSNESS 460 0.0036
749 MALIGNANT MELANOMA 48 0.0036
750 ABSCESS 57 0.0036
751 GASTRIC HAEMORRHAGE 41 0.0036
752 PAIN 2183 0.0036
753 PSORIATIC ARTHROPATHY 144 0.0035
754 ARTHROPATHY 197 0.0035
755 DRUG INTERACTION 560 0.0035
756 SWELLING 330 0.0035
757 FEMUR FRACTURE 109 0.0035
758 INTENTIONAL PRODUCT MISUSE 308 0.0035
759 PRODUCT QUALITY ISSUE 477 0.0035
760 BONE DENSITY DECREASED 110 0.0035
761 RESPIRATORY DEPRESSION 43 0.0035
762 HEART RATE DECREASED 123 0.0035
763 INTESTINAL OBSTRUCTION 132 0.0035
764 GAIT INABILITY 117 0.0035
765 HEMIPARESIS 59 0.0035
766 BLOOD GLUCOSE DECREASED 167 0.0035
767 WOUND INFECTION 38 0.0035
768 ABNORMAL BEHAVIOUR 137 0.0035
769 HAIR COLOUR CHANGES 43 0.0035
770 WEIGHT FLUCTUATION 36 0.0034
771 APPLICATION SITE PRURITUS 78 0.0034
772 DEVICE DISLOCATION 149 0.0034
773 DRUG ADMINISTRATION ERROR 105 0.0034
774 DERMATITIS ALLERGIC 43 0.0034
775 INJECTION SITE REACTION 235 0.0034
776 HERNIA 66 0.0034
777 SKIN REACTION 48 0.0034
778 BLINDNESS UNILATERAL 48 0.0034
779 INCREASED APPETITE 65 0.0034
780 ULCER 54 0.0034
781 EYE DISORDER 111 0.0034
782 PRESCRIBED UNDERDOSE 67 0.0034
783 WITHDRAWAL SYNDROME 141 0.0034
784 MULTIPLE ORGAN DYSFUNCTION SYNDROME 95 0.0034
785 HYPERTHYROIDISM 48 0.0033
786 DISEASE PROGRESSION 392 0.0033
787 COMPLICATION ASSOCIATED WITH DEVICE 48 0.0033
788 DYSKINESIA 134 0.0033
789 STATUS EPILEPTICUS 37 0.0033
790 MOUTH ULCERATION 69 0.0033
791 RENAL IMPAIRMENT 275 0.0033
792 CONVULSION 187 0.0033
793 CEREBRAL HAEMORRHAGE 117 0.0033
794 HIP ARTHROPLASTY 50 0.0033
795 DRUG LEVEL INCREASED 54 0.0033
796 INFLAMMATION 168 0.0033
797 PRODUCT TASTE ABNORMAL 44 0.0032
798 SEDATION 85 0.0032
799 SPINAL PAIN 38 0.0032
800 INFECTION 469 0.0032
801 HYPERGLYCAEMIA 118 0.0032
802 DEPRESSED LEVEL OF CONSCIOUSNESS 128 0.0032
803 GENERAL PHYSICAL HEALTH DETERIORATION 374 0.0032
804 ARRHYTHMIA 153 0.0032
805 IMPAIRED GASTRIC EMPTYING 44 0.0032
806 MALAISE 1412 0.0032
807 ILEUS 40 0.0032
808 TOOTH EXTRACTION 40 0.0032
809 HALLUCINATION, AUDITORY 51 0.0032
810 BRADYCARDIA 170 0.0032
811 SEIZURE 370 0.0032
812 ROAD TRAFFIC ACCIDENT 134 0.0032
813 GENERALISED TONIC-CLONIC SEIZURE 53 0.0032
814 NO THERAPEUTIC RESPONSE 39 0.0032
815 PANCREATITIS 168 0.0032
816 COLITIS ULCERATIVE 142 0.0032
817 GLOMERULAR FILTRATION RATE DECREASED 39 0.0032
818 MENTAL DISORDER 138 0.0032
819 EMOTIONAL DISORDER 97 0.0031
820 AGGRESSION 156 0.0031
821 SKIN CANCER 67 0.0031
822 ADVERSE DRUG REACTION 279 0.0031
823 VISUAL IMPAIRMENT 384 0.0031
824 OCULAR HYPERAEMIA 147 0.0031
825 POLYNEUROPATHY 37 0.0031
826 DEMENTIA 86 0.0031
827 HAEMATEMESIS 78 0.0031
828 RENAL DISORDER 143 0.0031
829 APPLICATION SITE RASH 42 0.0031
830 ADRENAL INSUFFICIENCY 37 0.0030
831 COMA 145 0.0030
832 HEPATIC CIRRHOSIS 57 0.0030
833 SEROTONIN SYNDROME 58 0.0030
834 IMMUNODEFICIENCY 45 0.0030
835 HYPOCALCAEMIA 57 0.0030
836 FEEDING DISORDER 61 0.0030
837 CARDIAC DISORDER 280 0.0030
838 KNEE ARTHROPLASTY 63 0.0030
839 LIVER FUNCTION TEST INCREASED 64 0.0030
840 DEVICE MALFUNCTION 209 0.0030
841 ECONOMIC PROBLEM 45 0.0030
842 INCORRECT PRODUCT STORAGE 39 0.0030
843 DRUG-INDUCED LIVER INJURY 93 0.0030
844 DISCOMFORT 180 0.0029
845 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 50 0.0029
846 TYPE 2 DIABETES MELLITUS 99 0.0029
847 HYPOGLYCAEMIA 142 0.0029
848 GASTROINTESTINAL DISORDER 262 0.0029
849 DRUG INEFFECTIVE 3829 0.0029
850 CARDIAC ARREST 239 0.0029
851 PANCREATITIS ACUTE 65 0.0029
852 EYE PRURITUS 97 0.0029
853 C-REACTIVE PROTEIN INCREASED 105 0.0029
854 RHEUMATOID ARTHRITIS 327 0.0029
855 BLOOD PRESSURE SYSTOLIC INCREASED 56 0.0029
856 PALLOR 78 0.0029
857 CHOLESTASIS 55 0.0029
858 LYMPHOMA 44 0.0028
859 PLATELET COUNT INCREASED 37 0.0028
860 HAEMORRHAGE INTRACRANIAL 42 0.0028
861 ELECTROCARDIOGRAM QT PROLONGED 101 0.0028
862 DIABETES MELLITUS 212 0.0028
863 CARDIAC FAILURE 222 0.0028
864 DRUG DISPENSING ERROR 42 0.0027
865 HEPATITIS 70 0.0027
866 BLOOD GLUCOSE INCREASED 515 0.0027
867 PSYCHOTIC DISORDER 80 0.0027
868 PROCEDURAL PAIN 75 0.0027
869 DEVICE ISSUE 242 0.0027
870 INJECTION SITE HAEMATOMA 39 0.0027
871 DEVICE EXPULSION 173 0.0027
872 NEUTROPENIA 361 0.0027
873 ANHEDONIA 69 0.0026
874 HYPOACUSIS 113 0.0026
875 ANAPHYLACTIC REACTION 145 0.0026
876 EYE IRRITATION 151 0.0026
877 HAEMORRHAGE 274 0.0026
878 CEREBRAL INFARCTION 64 0.0026
879 SHOCK 60 0.0026
880 BLOOD CREATINE PHOSPHOKINASE INCREASED 75 0.0026
881 CARDIOGENIC SHOCK 37 0.0026
882 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 60 0.0026
883 INCORRECT ROUTE OF DRUG ADMINISTRATION 92 0.0026
884 GAMMA-GLUTAMYLTRANSFERASE INCREASED 57 0.0026
885 DRUG TOXICITY 35 0.0026
886 CEREBROVASCULAR ACCIDENT 435 0.0026
887 DRUG PRESCRIBING ERROR 49 0.0025
888 MUSCULOSKELETAL DISORDER 48 0.0025
889 ACUTE MYELOID LEUKAEMIA 39 0.0025
890 LIVER INJURY 61 0.0025
891 INSURANCE ISSUE 38 0.0025
892 MUCOSAL INFLAMMATION 65 0.0025
893 CARDIO-RESPIRATORY ARREST 103 0.0025
894 AMENORRHOEA 43 0.0024
895 UNDERDOSE 179 0.0024
896 MULTIPLE FRACTURES 40 0.0024
897 PRODUCT PHYSICAL ISSUE 49 0.0024
898 INCORRECT DOSE ADMINISTERED 554 0.0024
899 RHABDOMYOLYSIS 101 0.0024
900 ANGIOEDEMA 107 0.0024
901 LIVER DISORDER 107 0.0024
902 PREGNANCY 48 0.0024
903 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
904 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 169 0.0024
905 LEUKOPENIA 118 0.0024
906 MYOCARDIAL INFARCTION 411 0.0024
907 COLON CANCER 35 0.0023
908 LOWER RESPIRATORY TRACT INFECTION 106 0.0023
909 INTENTIONAL PRODUCT USE ISSUE 202 0.0023
910 ANAPHYLACTIC SHOCK 59 0.0023
911 TOXICITY TO VARIOUS AGENTS 385 0.0023
912 PERITONITIS 47 0.0023
913 METASTASES TO BONE 37 0.0023
914 LACTIC ACIDOSIS 73 0.0023
915 HOSPITALISATION 345 0.0022
916 THERAPY NON-RESPONDER 100 0.0022
917 METASTASES TO LIVER 39 0.0022
918 PRODUCT USE ISSUE 416 0.0022
919 NERVOUS SYSTEM DISORDER 68 0.0022
920 CIRCULATORY COLLAPSE 37 0.0022
921 EXTRA DOSE ADMINISTERED 88 0.0022
922 ACCIDENTAL OVERDOSE 79 0.0022
923 EXPIRED PRODUCT ADMINISTERED 71 0.0021
924 MALIGNANT NEOPLASM PROGRESSION 216 0.0021
925 INTERSTITIAL LUNG DISEASE 102 0.0021
926 SURGERY 123 0.0021
927 DRUG INTOLERANCE 202 0.0021
928 THERAPY INTERRUPTED 148 0.0021
929 PRESCRIBED OVERDOSE 40 0.0021
930 OFF LABEL USE 1808 0.0021
931 ECZEMA 107 0.0020
932 PRODUCT PRESCRIBING ERROR 48 0.0020
933 BLOOD GLUCOSE ABNORMAL 37 0.0020
934 OVERDOSE 431 0.0020
935 TREATMENT NONCOMPLIANCE 109 0.0020
936 CARDIOVASCULAR DISORDER 50 0.0020
937 INTENTIONAL DRUG MISUSE 41 0.0020
938 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
939 INFUSION RELATED REACTION 128 0.0019
940 PROTEINURIA 36 0.0019
941 ILL-DEFINED DISORDER 114 0.0019
942 ABORTION SPONTANEOUS 74 0.0018
943 INTENTIONAL DOSE OMISSION 52 0.0018
944 RESPIRATORY ARREST 49 0.0018
945 INTENTIONAL OVERDOSE 113 0.0018
946 DIABETIC KETOACIDOSIS 42 0.0017
947 DISEASE RECURRENCE 83 0.0017
948 TOOTH LOSS 36 0.0017
949 EXPOSURE DURING PREGNANCY 107 0.0017
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 58 0.0017
951 SUICIDE ATTEMPT 104 0.0017
952 LUNG NEOPLASM MALIGNANT 70 0.0017
953 THERAPEUTIC RESPONSE DECREASED 102 0.0017
954 TARDIVE DYSKINESIA 47 0.0017
955 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 42 0.0016
956 DRUG WITHDRAWAL SYNDROME 143 0.0016
957 NEEDLE ISSUE 47 0.0016
958 DRUG EXPOSURE DURING PREGNANCY 54 0.0016
959 EMOTIONAL DISTRESS 192 0.0016
960 OSTEONECROSIS OF JAW 38 0.0015
961 ADVERSE EVENT 141 0.0015
962 OSTEONECROSIS 50 0.0015
963 DEATH 1306 0.0015
964 HEPATIC FUNCTION ABNORMAL 56 0.0015
965 NEOPLASM PROGRESSION 52 0.0015
966 SYSTEMIC LUPUS ERYTHEMATOSUS 53 0.0015
967 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
968 BLINDNESS 59 0.0014
969 PRODUCT ADHESION ISSUE 50 0.0014
970 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 243 0.0013
971 COVID-19 233 0.0013
972 EPILEPSY 40 0.0013
973 BREAST CANCER 121 0.0013
974 PRODUCT USE IN UNAPPROVED INDICATION 312 0.0013
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 255 0.0013
976 NEOPLASM MALIGNANT 80 0.0012
977 THERAPEUTIC RESPONSE SHORTENED 39 0.0012
978 THERAPEUTIC PRODUCT EFFECT DECREASED 51 0.0011
979 DEVICE LEAKAGE 45 0.0010
980 PROSTATE CANCER 79 0.0010
981 DEVICE BREAKAGE 38 0.0009
982 ILLNESS 93 0.0009
983 TREATMENT FAILURE 73 0.0009
984 PRODUCT DOSE OMISSION ISSUE 242 0.0008
985 MATERNAL EXPOSURE DURING PREGNANCY 71 0.0008
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 37 0.0008
987 FOETAL EXPOSURE DURING PREGNANCY 58 0.0007
988 DEVICE DIFFICULT TO USE 35 0.0005
989 COMPLETED SUICIDE 44 0.0005
990 ACCIDENTAL EXPOSURE TO PRODUCT 50 0.0005
991 NO ADVERSE EVENT 85 0.0005
992 DRUG DEPENDENCE 63 0.0004